CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 68 filers reported holding CATALYST BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17 | -75.4% | 48,633 | -62.9% | 0.00% | -88.9% |
| Q4 2022 | $69 | -99.9% | 131,218 | -30.6% | 0.01% | 0.0% |
| Q3 2022 | $95,000 | -1.0% | 189,175 | +250.5% | 0.01% | +12.5% |
| Q2 2022 | $96,000 | +123.3% | 53,977 | +13.8% | 0.01% | +100.0% |
| Q4 2021 | $43,000 | -64.2% | 47,441 | +63.0% | 0.00% | -63.6% |
| Q3 2021 | $120,000 | -78.9% | 29,103 | +32.3% | 0.01% | -64.5% |
| Q1 2018 | $568,000 | – | 21,997 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 202,281 | $2,759,000 | 1.56% |
| ACUTA CAPITAL PARTNERS, LLC | 450,000 | $6,138,000 | 1.16% |
| NEXTHERA CAPITAL LP | 311,175 | $4,244,000 | 0.78% |
| Avoro Capital Advisors LLC | 400,000 | $5,456,000 | 0.35% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $818,000 | 0.34% |
| B. Riley Wealth Advisors, Inc. | 62,500 | $853,000 | 0.12% |
| Kalos Management, Inc. | 12,100 | $222,000 | 0.10% |
| J. Goldman & Co LP | 124,500 | $1,698,000 | 0.09% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $205,000 | 0.02% |
| DRW Securities, LLC | 12,000 | $164,000 | 0.02% |